Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are at high risk of liver cancer, including those with liver cirrhosis, chronic hepatitis B, a current or past diagnosis of liver cancer, or adults who have had a liver transplant or are being monitored after a liver transplant
- People who had two specific types of imaging scans — a contrast-enhanced ultrasound (CEUS) and either a contrast-enhanced CT or MRI scan — within the 2 months before surgery
- People who have clear results from a surgical tissue sample or a needle biopsy confirming their diagnosis
- People whose clinical records, imaging scans, and tissue sample results are all complete and available
Who may not be able to join:
- People under 18 years of age, or people whose liver cirrhosis is caused by certain specific conditions, including a condition present from birth affecting liver tissue, a liver or blood vessel disease, or widespread abnormal nodules in the liver (confirm with trial site)
- People who have already received drug-based treatments such as chemotherapy, immunotherapy, or targeted therapy, or who have had procedures performed directly on the liver lesion, such as a procedure to block blood flow to a tumour (TACE), radiation therapy, or heat-based treatments like radiofrequency or microwave ablation
- People whose pre-surgery imaging scans or surgical tissue sample images are of poor quality or are incomplete
- People whose contrast-enhanced ultrasound showed a specific pattern of blood flow around the edge or in a ring shape around the liver lesion (confirm with trial site for exact technical details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18768197675
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
pathology results
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.